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ARTICLE
The WHHERE coactivator complex is required for
retinoic acid-dependent regulation of embryonic
symmetry
Gonçalo C. Vilhais-Neto1,2, Marjorie Fournier1, Jean-Luc Plassat1, Mihaela E. Sardiu2, Anita Saraf2,
Jean-Marie Garnier1, Mitsuji Maruhashi1,2, Laurence Florens2, Michael P. Washburn 2,3
& Olivier Pourquié 1,2,4,5,6
Bilateral symmetry is a striking feature of the vertebrate body plan organization. Vertebral
precursors, called somites, provide one of the best illustrations of embryonic symmetry.
Maintenance of somitogenesis symmetry requires retinoic acid (RA) and its coactivator
Rere/Atrophin2. Here, using a proteomic approach we identify a protein complex, containing
Wdr5, Hdac1, Hdac2 and Rere (named WHHERE), which regulates RA signaling and controls
embryonic symmetry. We demonstrate that Wdr5, Hdac1, and Hdac2 are required for RA
signaling in vitro and in vivo. Mouse mutants forWdr5 and Hdac1 exhibit asymmetrical somite
formation characteristic of RA-deﬁciency. We also identify the Rere-binding histone
methyltransferase Ehmt2/G9a, as a RA coactivator controlling somite symmetry. Upon RA
treatment, WHHERE and Ehmt2 become enriched at RA target genes to promote RNA
polymerase II recruitment. Our work identiﬁes a protein complex linking key epigenetic
regulators acting in the molecular control of embryonic bilateral symmetry.
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The development of bilaterally symmetrical structures, suchas limbs or somites takes place concomitantly with theasymmetric formation of internal organs such as heart, gut,
and liver. Whereas the pathway responsible for establishing
left–right identity in the embryo begins to be well understood1,
little is known about the mechanisms controlling embryonic
symmetry. Retinoic acid (RA) is a derivative of vitamin A,
signaling via a heterodimeric RAR/RXR nuclear receptor
transcription factor2–4. In the absence of RA, the heterodimer
binds target genes together with the SMRT and NCoR
corepressor complexes and histone deacetylases such as Hdac3 to
silence gene expression. When the RA ligand binds to RAR, the
corepressors are replaced by a set of coactivators including
histone acetyltransferases, contributing to active transcription of
RA target genes5, 6. In the absence of RA signaling in the mouse
embryo, somite formation becomes asymmetrical, showing a
signiﬁcant delay on the right side7. A similar somite desynchro-
nization phenotype is also observed in mutants for the protein
Rere (or Atrophin2) which acts as a coactivator for RA signalling8.
Here, we identify and characterize biochemically a previously
undescribed retinoic coactivator complex, containing the proteins
Wdr5, Hdac1, Hdac2, and Rere (the WHHERE complex). We
demonstrate that mouse mutants of the WHHERE complex
members down-regulate RA signaling and exhibit somite bilateral
symmetry defects. We report that the WHHERE complex also
binds the histone methyltransferase Ehmt2/G9a. Null mouse
mutants for Ehmt2 also exhibit RA downregulation and somite
symmetry defects indicating that it also acts as an activator of RA
signaling. We show that Ehmt2 and the WHHERE complex bind
to the promoter of RA targets and serve to recruit PolII to trigger
gene activation.
Results
Identiﬁcation of the WHHERE complex. In order to understand
the mechanism of action of Rere in the RA pathway controlling
somite symmetry, we ﬁrst set out to identify Rere-interacting
proteins in the mouse mesoderm. To that end, we generated a
transgenic mouse line, which allows the conditional expression
of a tagged version of Rere containing two HA epitopes at the
C-terminal end of the protein (Rere-HA). A Rere-HA construct
preceded by a LoxP-STOP-LoxP cassette was introduced into the
Rosa26 locus by homologous recombination in mouse embryonic
stem (ES) cells. We then used these cells to generate a Rosa26-
LoxP-STOP-LoxP-Rere-HA mouse line (RS-Rere-HA line).
Whereas Rere mutants (Rereom/om) die around E9.5 with defects
in forebrain, heart and a right side speciﬁc delay in somite
formation8, 9, expression of at least one Rere-HA allele in the
mutant Rereom/om background led to morphologically normal
embryos (Supplementary Fig. 1a–c). Therefore, the tagged
Rere-HA protein is functional in vivo.
To direct expression of Rere-HA to the mesoderm, RS-Rere-
HA mice were crossed to the T-Cre mouse line10. We prepared
whole cell protein extracts from ~ 600 RS-Rere-HA;T-Cre
embryos, and performed afﬁnity puriﬁcation using anti-HA
antibodies under high or low salt conditions (Fig. 1a). To identify
the immunoprecipitated proteins, eluted fractions were submitted
to mass spectrometry analysis using the multidimensional protein
identiﬁcation technology (MudPIT)11. A set of 105 common
proteins was found between the different immunopuriﬁcation
conditions (Supplementary Figs. 1d, 6 and Supplementary Data 1).
Hierarchical clustering analysis of the 105 proteins based on
the normalized spectral abundance factor (NSAF)12 in
the different immunoprecipitation conditions identiﬁed three
abundant proteins tightly clustering with Rere (Supplementary
Fig. 1e, f). These include Rere’s known binding partners Hdac1
and Hdac2 as well as a previously unreported partner, Wdr513–16
(Fig. 1b, Supplementary Figs. 2a and 9). To estimate relative
protein levels, we compared the NSAF values for each protein12.
NSAF for Rere, Hdac1, and Hdac2 were similar while it was three
times higher for Wdr5 (Fig. 1b). These results suggest that the
proteins Rere, Hdac1, Hdac2, and Wdr5 can interact in the
mesoderm.
In vitro characterization of the WHHERE complex. To validate
the identiﬁcation of Wdr5 as an interacting partner of Rere,
Hdac1, and Hdac2, we co-expressed tagged versions of the four
proteins (Rere-Flag, Flag-Hdac1, Flag-Hdac2, and HA-Wdr5)
using a baculovirus-insect cell expression system. After
Flag immunoprecipitation of Rere, Hdac1 and Hdac2, HA-Wdr5
was detected in the eluates, as conﬁrmed by LC−MS/MS analysis
of the Coomassie stained gel bands (Fig. 1c, Supplementary
Figs. 2b and 7). The four proteins still co-puriﬁed together at
high salt concentration (500 mM KCl) suggesting the
existence of a stable protein complex comprising Rere, Hdac1,
Hdac2, and Wdr5 (Fig. 1c and Supplementary Fig. 7). By
co-immunoprecipitation of baculovirus-expressed Rere-Flag and
HA-Wdr5, we could demonstrate that Rere binds directly to
Wdr5 (Fig. 1d and Supplementary Fig. 7). Wdr5 does not bind
directly to Hdac1 or Hdac2 in high or low salt wash conditions
(Supplementary Figs. 2c and 9). Wdr5 binding to Hdac1 and
Hdac2 could only be detected when Rere is also co-expressed
(Supplementary Figs. 2c and 9), suggesting that Rere acts as a
scaffolding component binding Hdac1/Hdac2 and Wdr5.
To analyze whether the four co-immunopuriﬁed proteins
form a stable protein complex, we carried out gel ﬁltration
chromatography followed by western blot and mass spectrometry
analysis. All four proteins co-eluted together in a fraction cor-
responding to a high molecular weight complex of 0.5–0.6 MDa
(Figs. 1e, f, Supplementary Figs. 2d, e and 7). This molecular
weight is consistent with the abundance predicted by the NSAF
values of the proteomic analysis. Additionally, Hdac1, Hdac2, and
Wdr5 co-immunoprecipitated with the endogenous Rere
in NIH3T3 cells further supporting the existence of such a
protein complex (Fig. 1g and Supplementary Fig. 7). Altogether,
these results suggest that Wdr5, Hdac1, Hdac2 and Rere can
form a stable protein complex, which we called the WHHERE
complex.
WHHERE complex members act as coactivators of RA sig-
naling. To test the coactivator properties of WHHERE on RA
signaling, we transfected NIH3T3 ﬁbroblast cells with expression
vectors coding for either Rere, Wdr5, Hdac1, or Hdac2, together
with a RA reporter containing the well-characterized retinoic acid
response element (RARE) of the known RA target retinoic Acid
Receptor beta (Rarβ)17, driving luciferase expression. In the
presence of RA, overexpression of each of the four WHHERE
complex proteins increased RA reporter expression (Fig. 2a). This
activation was not observed in the absence of RA (Supplementary
Fig. 3a). Also overexpression of the WHHERE complex compo-
nents did not activate either a minimal or a SV40 promoter
driving luciferase supporting the speciﬁcity of the RA response
(Supplementary Fig. 3b, c). Furthermore, co-transfection of
Hdac1 and Hdac2 cooperated to activate RA signaling (Fig. 2b).
Conversely, treatment of ﬁbroblast cultures with siRNAs against
Rere, Hdac1, or Wdr5 in the presence of RA decreased RARE-
Luciferase reporter activity (Fig. 2c and Supplementary Fig. 3d–f).
Treatment with Hdac2 siRNA led to an increase of RARE-
Luciferase reporter activity (Fig. 2c and Supplementary Fig. 3g),
which might be explained by a stabilization of Hdac1 (due to the
decrease of Hdac2), potentially resulting in an increase in RA
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signalling18, 19. Consistent with this possibility, the double
knockdown of Hdac1 and Hdac2 further decreased RA signaling
compared to Hdac1 siRNA alone (Fig. 2d). Furthermore, Hdac1
or Hdac1/Hdac2 depletion reduced RA activation mediated by
Rere and Wdr5 (Fig. 2e, f). Inhibition of deacetylase enzymatic
activity with a range of chemical inhibitors decreased RA signa-
ling (Fig. 2g)20. In line with this, overexpression of Rere or Wdr5
did not lead to a signiﬁcant increase in RA signaling when cells
were treated with the HDAC inhibitors Trichostatin A (TSA) or
sodium butyrate (SB) (Fig. 2h, i). Hdac1 and Hdac2 have been
shown to bind Rere N-terminal region9, 13, 14. In the presence of
RA, overexpression of the N-terminal region of Rere (N-Rere)
strongly increased RA signaling whereas no activation could
be seen with Rere C-terminal region (Rere C) (Fig. 2j). The
activation by N-Rere was dependent on deacetylase activity since
TSA or SB treatment strongly decreased N-Rere-dependent RA
signaling (Fig. 2k). Overall, these results show that the WHHERE
complex proteins Rere, Wdr5, Hdac1, and Hdac2 act to activate
the RA pathway in NIH3T3 cells. Moreover, activation of RA
signaling by the WHHERE complex depends on Hdac1 and
Hdac2 deacetylase activity.
WHHERE regulates RA signaling and somite bilateral sym-
metry. To analyze WHHERE-dependent RA regulation in vivo,
we characterized the phenotype of mouse embryos mutant for the
different components of the complex. Hdac1 mutants exhibit a
variety of developmental defects similar to Rereom/om embryos21.
We introduced the RARE-LacZ reporter22 in Hdac1-null embryos
and observed a strong downregulation of LacZ expression, similar
to that seen in Rere mutants (Fig. 3a–c). Hdac2 mutants do not
show developmental defects and can survive until the perinatal
period21. To analyze Wdr5 function in vivo we ﬁrst set out to
generate a conditional knockout mouse line by introducing
LoxP sites ﬂanking exons 2 to exon 4 (Supplementary Fig. 4a).
No heterozygous embryos were recovered at E8.5 after crossing
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Fig. 1 Proteomic identiﬁcation of the WHHERE protein complex containing Wdr5, Hdac1, Hdac2, and Rere. a Schematic workﬂow for the proteomic strategy
used to identify Rere-associated proteins. b Hierarchical clustering of the NSAF values showing Wdr5, Hdac1, and Hdac2 clustering with Rere identiﬁed by
MudPIT. Columns correspond to different immunoprecipitations conditions. Table showing the peptide count, spectral count, sequence coverage (%) and
average NSAF values for Rere, Wdr5, Hdac1, and Hdac2. c SDS-PAGE gel stained with Coomassie blue after Flag immunopuriﬁcation at low (150mM KCl)
and high (500mM KCl) salt wash of the recombinant WHHERE complex from baculoviruses infected cells co-expressing Rere-Flag, Flag-Hdac1,
Flag-Hdac2, and HA-Wdr5. Identiﬁcation of the different components was conﬁrmed by LC–MS/MS analysis of the corresponding gel bands. d Flag
immunoprecipitation from extracts of cells infected with baculoviruses expressing HA-Wdr5 and Rere-Flag. Flag and HA western blot. The three bands
recognized by the anti-Flag antibodies correspond to Rere and its degradation products. e Gel ﬁltration chromatography proﬁle of the WHHERE complex
puriﬁed from baculoviruses infected cells co-expressing Rere-Flag, Flag-Hdac1, Flag-Hdac2, and HA-Wdr5. f Immunoblot analysis for Rere, Hdac1, Hdac2,
and Wdr5 showing the gel ﬁltration chromatography elution fractions from A8 to B2. g Rere immunoprecipitation from NIH3T3 cells identifying the
endogenous WHHERE complex components. Rere, Hdac1, Hdac2, and Wdr5 were detected after western blot analysis of Rere immunoprecipitation eluates
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NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00593-6 ARTICLE
NATURE COMMUNICATIONS |8:  728 |DOI: 10.1038/s41467-017-00593-6 |www.nature.com/naturecommunications 3
with an ubiquitous Cre suggesting that the Wdr5 mutation is
heterozygous lethal at early stages. To circumvent this issue, we
crossed mice homozygous for the Wdr5 conditional allele
(Wdr5ﬂ/ﬂ) to the mesoderm-speciﬁc T-Cre line10. Removal of a
single Wdr5 allele in Wdr5ﬂ/+;T-Cre;RARE-LacZ embryos was
sufﬁcient to strongly decrease β-galactosidase staining in the
mesoderm (Fig. 3d). In contrast, no signiﬁcant downregulation of
Notch target genes such as Lfng or Hes7 was detected in these
mutants suggesting the Notch-dependent somite segmentation
clock appears normal (Supplementary Fig. 4b–e). Altogether,
these results support the function of the WHHERE complex in
the control of RA signaling in the embryo.
We next examined the effect of null mutations of members of
the WHHERE complex on somite symmetry. In nearly half of the
Hdac1–/– embryos, we observed a right side delay of somite
formation resembling the defect observed in Rereom/om and
Raldh2–/– mutants7, 8 (Fig. 3e–g, i, j and Supplementary Fig. 4f).
Similar lateralized somite desynchronization defects were
observed in a limited number of Wdr5ﬂ/+;T-Cre embryos which
also exhibited broad somitogenesis defects (Fig. 3h). We next
intercrossed Wdr5ﬂ/+ and Rere;T-Cre mice. Strikingly Rereom/om;
Wdr5ﬂ/+;T-Cre embryos exhibited a stronger phenotype
than either Rereom/om or Wdr5ﬂ/+;T-Cre (Fig. 3l–o) with ~ 80%
(7 out of 9) of the embryos with a right side delay in
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Fig. 2 The WHHERE complex acts as a coactivator for retinoic acid signaling. a-k RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for
20 h. a Cells transfected with expression plasmids containing Rere, Wdr5, Hdac1, or Hdac2 (n= 4). b Cells transfected with expression plasmids containing
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somitogenesis (Fig. 3k and Supplementary Fig. 4f) and in ~ 35%
(3 out 9) of the embryos, no clear segmented structures forming
on the right side (Fig. 3o and Supplementary Fig. 4g, h). This
provides strong evidence for genetic interaction between Wdr5
and Rere in the control of somite symmetry. Consistently,
transfection of Rere and Wdr5 together in NIH3T3 cells activated
RA signaling more strongly than overexpression of either of the
proteins alone (Fig. 2l) and Rere-dependent RA activation is no
longer observed in cells depleted ofWdr5 (Fig. 2m). Overall, these
data reveal the importance of WHHERE in positive regulation of
RA signaling and in the control of somitogenesis synchronization
in mouse embryos.
WHHERE is required to recruit PolII to RA targets’ promoter.
Next we analyzed the binding of the WHHERE complex to
RA regulated genes by chromatin immunoprecipitation (ChIP).
To that end, we ﬁrst checked the expression kinetics of the RARE-
Luciferase reporter and of the endogenous Rarβ gene in NIH3T3
cells treated with RA for 1, 2, and 6 h. At 2 and 6 h, strong
transcriptional activation was observed for both RA targets
(Fig. 4a, b). In mouse embryos, we observed by ChIP analysis
that the retinoic acid receptor alpha (Rarα) and all the WHHERE
complex components were present at the Rarβ promoter and
at the RARE-containing reporter RARE-LacZ (Fig. 4c–f). In
ChIP experiments performed 1 h after RA treatment of NIH3T3
cells, Rere, Wdr5, Hdac1, and Hdac2 but not Rarα increased at
the Rarβ promoter (Fig. 4g, h). This effect was speciﬁc, as
no signiﬁcant enrichment of WHHERE complex members
could be observed in regions upstream of the Rarβ promoter
in similar conditions (Fig. 4h, bottom graph). Recruitment of
RNA Polymerase II (Pol II) increased following RA treatment
paralleling the WHHERE complex recruitment (Fig. 4i). Then
we investigated the requirement of Hdac1 deacetylase activity
in transcription activation and Pol II recruitment during
RA signaling. Decreased RARE-Luciferase and Rarβ expression
was observed in TSA-treated cells after RA treatment demon-
strating the importance of HDAC activity in early activation
of RA target genes (Fig. 4a, b). TSA treatment or siRNA-mediated
knockdown of Hdac1 decreased Pol II recruitment at the
Rarβ promoter (Fig. 4j, k). In contrast, no change in Pol II
occupancy levels could be detected in RA target genes
unresponsive to RA in NIH3T3 cells, such as Cyp26a1 and
Hoxa1 or in promoters of genes unresponsive to RA signaling
following such treatments (Supplementary Fig. 3k–m). In
transfected cells expressing Flag-Hdac1 alone or Flag-Hdac1 and
Rere-HA, we observed binding of Hdac1 to endogenous Rarα.
This suggests that Hdac1 could bridge the WHHERE complex
to Rarα (Fig. 4l–n and Supplementary Fig. 8). Together, these
data support a role of the WHHERE complex in the
recruitment of Pol II necessary for early activation of RA
regulated genes. This role depends on the deacetylase activity of
Hdac1 and Hdac2.
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Uncx4.1 in wild-type l, Wdr5ﬂ/+;T-Cre m, Rereom/om;Wdr5+/+ n and Rereom/om;Wdr5ﬂ/+;T-Cre o embryos at E8.75-E9.0 (dorsal views). For each genotype
at least 5–10 embryos were analyzed. Bar= 100 microns
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Ehmt2 acts together with WHHERE to activate RA signaling.
The histone methyltransferase Ehmt2 (G9a) was shown to
bind the N-terminal SANT domain of Rere, and together with
Hdac1/Hdac2 to regulate the methylation of H3K9 at speciﬁc loci
leading to the formation of compact heterochromatin and gene
silencing14. In the proteomic experiment, Ehmt2 (and the related
protein Ehmt1) were detected with low NSAF values compared to
the members of the WHHERE complex suggesting that its
binding to Rere might be transient (Supplementary Fig. 5a). In
mouse embryos deﬁcient for Ehmt223 crossed to the RARE-LacZ
reporter22, LacZ expression is downregulated suggesting that
Ehmt2 is also implicated in positive regulation of RA signaling
(Fig. 5a, b). Furthermore, half of the Ehmt2 mutant embryos
presented a delay in somite formation on the right side
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resembling mutants of members of the WHHERE complex
(Fig. 5c–e; Supplementary Fig. 4f). In NIH3T3 cultures, siRNA-
mediated knockdown of Ehmt2 led to a downregulation of the
RARE-Luciferase reporter activity (Fig. 5f and Supplementary
Fig. 3h), whereas overexpressing Ehmt2 (or Ehmt1) stimulates
RA signaling (Fig. 5g and Supplementary Fig. 5b).
Co-transfection of Ehmt2 with Rere increases the RA response
more than transfection of either one alone (Fig. 5h). siRNA-
mediated knockdown of Ehmt2 inhibited Rere and Hdac1-
dependent activation of the RA pathway (Fig. 5i). In NIH3T3
cells, Ehmt2 was recruited at the RARE element of the Rarβ
promoter after 1 h of RA treatment while no such enrichment was
observed in upstream regions (Fig. 5j and Supplementary Fig. 5c).
In mouse embryos Ehmt2 could also be detected at the RARE
element present in both the Rarβ promoter and the RARE-LacZ
reporter (Fig. 4o, p). Knockdown of Ehmt2 in NIH3T3 cells
reduced the occupancy levels of Rere, Wdr5, Hdac1, Hdac2, and
Pol II at the Rarβ promoter (Fig. 5k, l and Supplementary
Fig. 5d). In NIH3T3 cells, inhibition of Ehmt2 methyltransferase
activity with UNC0638 (U38) or UNC0646 (U46)24, 25 did
not alter RARE-Luciferase reporter activity or Rarβ mRNA
expression (Supplementary Fig. 5e, f). Also no difference in
H3K9me1 nor H3K9me2 levels was observed by ChIP after 1 h of
RA treatment suggesting that Ehmt2 function is independent
from its methyltransferase activity (Supplementary Fig. 5g, h).
This suggests that Ehmt2 could function as a scaffold protein to
stabilize the WHHERE complex at RA regulated genes to allow
Pol II loading. Thus, these results indicate that Ehmt2
acts together with the WHHERE coactivator complex in the
RA-dependent control of somite bilateral symmetry.
Effect of RA signaling on key histone marks. Wdr5 is part of
complexes such as ATAC, MOF, and MLL, that are involved in
histone acetylation and H3K4 methylation, which are chromatin
modiﬁcations associated with transcriptional activation26. Despite
the requirements of HDAC enzymatic activity for WHHERE
function, we observed an increase of the levels of acetylated H3
and H4 as well as H3K27ac on the Rarβ promoter upon 1 h of RA
treatment of NIH3T3 cells (Fig. 6a–c). This suggests that Hdac1
and Hdac2 might act on non-histone substrates or both could
participate to the stability of the WHHERE complex. The
H3K36me3 mark, which is associated to transcription elongation,
was also increased (Fig. 6d). We also found that in the same
conditions, H3K27me3 is absent from the Rarβ promoter
(Fig. 6e), whereas H3K4me1 increases while H3K4me2 and
H3K4me3 decrease (Fig. 6f–h). MLL3 and MLL4 are complexes
which contain Wdr5 and regulate the deposition of the H3K4me1
mark27. The MLL3 and MLL4 complexes have been shown to be
involved in RA-dependent transcription and Wdr5 might provide
a link with the WHHERE complex28. Whether these complexes
are also required for the WHHERE-dependent Pol II recruitment
to the promoter of RA targets remains to be investigated.
Negative regulation of RA signaling by Ep300. The histone
acetyl transferase Ep300 (p300) has been shown to acetylate
Hdac1 leading to a decrease of its deacetylase activity29. In the
presence of RA, overexpression of Ep300 in NIH3T3 cells
decreased RA signaling and inhibited Hdac1-dependent RA
activation (Fig. 7a). In line with this, transfection of an Hdac1
mutant form resistant to Ep300 acetylation (H1-6R)29 activated
more strongly the RA pathway than wild-type Hdac1 (H1-WT)
(Fig. 7b). Moreover, Rarα- and Rere-dependent RA activation was
inhibited following Ep300 overexpression whereas transfection of
the histone acetyl transferase Kat2a (Gcn5) together with Rarα or
Rere increased RA signaling more than transfection of either
construct alone (Fig. 7c, d). While treatment of ﬁbroblast cultures
with siRNAs against Rere or Kat2a in the presence of RA
decreased RA reporter activity, knockdown of Ep300 did not
affect the RA pathway (Fig.7e and Supplementary Fig. 3i, j).
Similarly in Ep300 mutant embryos (Ep300–/–)30, the RARE-LacZ
reporter22 expression appeared normal (Fig. 7f, g) and somito-
genesis progressed symmetrically (Figs. 7h, i). Altogether these
results demonstrated that Ep300 negatively regulates Hdac1
activation of RA signaling. Furthermore Kat2a can participate
together with the WHHERE complex in the activation of the RA
pathway.
Discussion
The molecular mechanisms controlling embryonic bilateral
symmetry are still poorly understood. In mouse, the only genes
shown to act in this process are Raldh2 and Rere which are
involved in the control of RA signaling7, 8. Here, we identify
a protein complex, called WHHERE which associates key
epigenetic regulators such as Wdr5, Hdac1, and Hdac2 to the
control of bilateral symmetry downstream of RA signaling. In the
background of a situs inversus mutation (a mutation that can
reverse left–right identity of the body), Raldh2 and Rere-deﬁcient
mouse embryos can show a reversed somite defect, i.e., left-side
delay of somitogenesis8, 31. This therefore argues that WHHERE-
dependent RA signaling buffers a desynchronizing inﬂuence of
the left−right determination pathway, involved in asymmetrical
development of internal organs. RA signaling was shown to
directly antagonize the left identity determinant Fgf8 in
the mouse embryo through recruitment of Hdac1 and Prc2,
providing a potential explanation for this buffering effect32, 33.
Thus, our work identiﬁes a new pathway antagonizing FGF
signaling acting downstream of RA to control bilateral symmetry
in the mouse embryo.
Strikingly most of the members of the WHHERE complex
including Rere, Hdac1, Hdac2, and also Ehmt2 have been
Fig. 4 The WHHERE complex is recruited to the promoter of retinoic acid target genes. a RARE-Luciferase activity, b qPCR analysis of Rarβ expression of
NIH3T3 treated with 1 µM RA (blue) or 1 µM RA and 100 nM TSA (green) (n= 4 each). c, d Rarβ-promoter ChIP analysis from E8.75 RARE-LacZ mouse
embryos with antibodies against Rarα c or Rere, Wdr5, Hdac1, and Hdac2 d. Top panels c, d: RARE element of the Rarβ promoter ChIP (n= 3). Bottom panels:
control ChIP from Rarβ promoter upstream region (−3 Kb). e, f ChIP analysis of the RARE sequence in the RARE-LacZ reporter with antibodies against
Rarα e or Rere, Wdr5, Hdac1, and Hdac2 f using E8.75 RARE-LacZ mouse embryos (n= 3). g–i ChIP analysis of Rarβ promoter in NIH3T3 treated or not
during 1 h with 1 µM RA using antibodies for Rarα g, Rere, Wdr5, Hdac1, and Hdac2 h, Pol II i. Top panels h, i: ChIP of the RARE element in the Rarβ-promoter
(n= 3). Bottom panels: control ChIP from Rarβ-promoter -upstream region (−3 Kb). j ChIP of the Rarβ promoter with Pol II antibody using NIH3T3 cells
treated with 1 µM RA or 1 µM RA and 100 nM TSA for 1 h (n= 3). k ChIP with Pol II antibody from NIH3T3 transfected with siRNA for Hdac1 and treated
with 1 µM RA during 1 h (n= 3). l–n Co-immunoprecipitation using NIH3T3 transfected with Flag-Hdac1 l, Rere-HA and Flag-Hdac1 m, n, with anti-Flag l, m
or anti-HA n antibody and immunoblots (IB) for Flag-Hdac1, Rere-HA, and Rarα. o Rarβ-promoter ChIP analysis from E8.75 RARE-LacZ mouse embryos
with an anti-Ehmt2. Top panel o: RARE element ChIP of the Rarβ promoter (n= 3). Bottom panel: control ChIP from Rarβ promoter upstream region (−3 Kb).
p ChIP analysis of the RARE sequence in the RARE-LacZ reporter with an anti- Ehmt2 using E8.75 RARE-LacZ mouse embryos (n= 3). Data represent
mean± s.e.m. unless otherwise speciﬁed. NS—not signiﬁcant, *P< 0.05 and **P< 0.01. Student’s unpaired two-tailed t-test
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generally associated to transcriptional repression34–36. However,
Rere was shown to act as a coactivator for RA signaling8 and
Hdac1/Hdac2 are required for transcriptional activation of the
MMTV promoter downstream of the glucocorticoid receptor29.
Ehmt2 has also been shown to participate in the positive
regulation of a subset of glucocorticoid receptor-regulated
genes37, 38. Our data show that in the context of RA signaling
these transcriptional repressors can form a complex, which acts
as a coactivator of the pathway. We further show that the acetyl
transferase Ep300 can reduce Rere-dependent RA signaling.
This raises the possibility that in this context, Ep300-dependent
acetylation of the retinoic acid receptors decreases their
transcriptional activity, an effect which could be reversed by
Hdac1/2 mediated deacetylation. Thus, studies like those reported
here may be necessary to fully understand the functions of
co-regulators, which may act as coactivators or corepressors
depending on the developmental context and genes involved. The
positive role of these proteins in signaling mediated by other
nuclear receptors suggests that the WHHERE complex could also
have a broader role as a coactivator downstream of nuclear
receptor signaling. The positive regulation of RA signaling by
Hdac1 and Hdac2 identiﬁed in this work might have signiﬁcant
implications for the potential use of HDAC inhibitors for the
treatment of RA-sensitive cancers39.
Methods
Generation of transgenic mice. The Rere-HA construct was generated by adding
two HA tags at the C-terminal extremity of Rere. Rere-HA was cloned downstream
of a loxP-STOP-loxP cassette and inserted into the Rosa26 locus by homologous
recombination in 129S6/SvEvTac-derived W4 embryonic stem (ES) cells40.
Animals were maintained on a 50% C57BL/6 genetic background.
Wdr5 conditional allele (Wdr5ﬂ/+) mice were generated by the Mouse Clinical
Institute (Illkirch-Graffenstaden) by inserting two loxP sites ﬂanking the region
encompassing exon 2 and exon 4 in C57BL/6N-derived ES cells (Supplementary
Fig. 4a). The Neo selection cassette ﬂanked by FRT site was removed in vivo using a
FlpO deleter mice41. Animals were maintained on a C57BL/6 genetic background.
Mice breeding and generation of mutant embryos. To remove the STOP
cassette from the RS-Rere-HA mouse line, we crossed this line with ZP3-Cre mice,
which express the Cre recombinase speciﬁcally in oocytes42. Mice in which the
STOP cassette was removed were subsequently intercrossed with Rereom/+ mice9.
The Rere-HA construct rescued the Rereom/+ mutation indicating that the protein
Rere-HA is functional (Supplementary Fig. 1a–c). In order to obtain embryos
expressing Rere-HA speciﬁcally in the mesoderm for proteomic experiments,
we generated a homozygous line for RS-Rere-HA and crossed it with homozygous
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T-Cre animals10. The Rereom/+ mouse line was obtained in an N-ethyl-N-
nitrosourea (ENU) screen9 and the line was maintained on a C57BL/6 genetic
background. To analyze conditional mutations of Wdr5, we crossed the Wdr5ﬂ/+
mouse line with T-Cre mice. The embryos Wdr5ﬂ/+;T-Cre used for analysis only
have one mutant allele in the mesodermal tissues. To generate the Hdac1+/– mouse
line, Hdac1ﬂ/ﬂ animals21 were crossed with ZP3-Cre mice42 and maintained on at
least 50% C57BL/6 genetic background. Heterozygous males and females Hdac1+/–
were then mated to obtain Hdac1–/– embryos. The gene-trap allele (gt) Ehmt2gt/+23
was maintained on at least 50% C57BL/6 genetic background. Embryos Ehmt2gt/gt
were obtained by mating heterozygous males and females for the Ehmt2 mutation.
The mouse mutant for Ep30030 was maintained on at least 50% C57BL/6 genetic
background. Heterozygous males and females Ep300+/− were then mated to obtain
Ep300−/− embryos. To study the status of RA signaling, the RARE-LacZ reporter
mice22 in which LacZ expression is driven by the RARE of the retinoic acid receptor
beta gene (Rarβ) were crossed to: Rereom/+, Wdr5ﬂ/+;T-Cre, Hdac1+/−, Ehmt2gt/+,
and Ep300–/– and the mutant embryos were analyzed for β-galactosidase activity
using X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside). The wild-type
and mutant embryos were always stained in the same conditions and same well for
1 h 30 min. All animal procedures were performed according to a protocol
approved by IGBMC (#2012-142), in agreement with national and international
guidelines.
Whole-mount in situ hybridization. Whole-mount in situ hybridizations were
performed according to the protocol described in ref. 43. Brieﬂy, formaldehyde-ﬁxed
embryos were treated with protease and reﬁxed with 4% formaldehyde/0.1%
glutaraldehyde. Hybridization with DIG-labeled RNA probes was performed under
stringent conditions (1.3X SSC, 50% formamide at 65 °C, pH 5) in a buffer containing
0.2% Tween-20 and 0.5% CHAPS. Washed embryos were treated with Boehringer
blocking reagent and incubated overnight in alkaline phosphatase-coupled anti-DIG
antibody. After extensive washes, embryos were stained from 30min to 16 h. The
probes used are described in the literature: Uncx4.144, Lfng45, and Hes746.
Vector construction and baculovirus generation. To assay RA signaling in
NIH3T3 cells, we used the RA reporter RARE-Luciferase and mouse Rere-HA
subcloned into pMyc-CMV (Sigma) described in ref. 8. The mouse full-length
Wdr5, Hdac1, Hdac2, and Rarα cDNAs were subcloned into pFlag-CMV (Sigma).
Human Flag-Ehmt2 in PCNF plasmid and Flag-Ehmt1 in pCDNA3 plasmid (both
from Nakatani lab) were used to assay RA signaling in NIH3T3 cells. Rere N-
terminal region (a.a. 1–571) (N-Rere) and Rere C-terminal region (a.a. 572–1558)
(Rere C) were subcloned into pMyc-CMV (Sigma) and pFlag-CMV (Sigma),
respectively. Human Hdac1 wild-type (H1-WT) and Hdac1 mutant (H1-6R) in
pEGFP-N1 (Clontech) was a gift from Gordon Hager. Human Ep300 in pCMVb
was a gift from Richard Eckner and mouse Kat2a (Gcn5) in pCMV-sport247
(Invitrogen) (Addgene plasmid 23098) was a gift from Sharon Dent.
For the generation of baculoviruses expressing Flag-Hdac1 and Flag-Hdac2, the
full-length cDNA encoding mouse Hdac1 and Hdac2 fused with a N-terminal Flag
tag, were cloned into the pVL1393 entry vector at BamHI and XbaI sites. For the
generation of baculoviruses expressing Rere-Flag, the full-length cDNA encoding
mouse Rere, was cloned into the pVL1392 entry vector at BplI and KpnI sites. The
viruses were then generated from these entry vectors following the transferring
genes protocol (Method I) described in Summers and Smith (1987) “A manual of
methods for baculo vectors and insect cell culture procedures”. The viruses
expressing HA-Wdr5 was provided by Dr. Laszlo Tora (IGBMC).
Cell culture, RA reporter assay and siRNA experiments. NIH3T3 cells were
cultured in DMEM (Invitrogen) containing 4,5 g/l D-glucose, L-glutamine, pyr-
uvate, and 10% newborn calf serum8. For RA reporter assay, when cells reached
50% conﬂuence in 24-well plates, they were co-transfected with RARE-pGL4.23
(200 ng), pGL3-Promoter (200 ng), pRL-CMV (5 ng) (Promega), TA-Luc (200 ng)
(Panomics) and the different expression constructs containing Rere, Wdr5, Hdac1,
Hdac2, Ehmt1, Ehmt2, N-Rere (Rere N-terminal region), Rere C (Rere C-terminal
region), Hdac1 wild-type (H1-WT), Hdac1 mutant (H1-6R), Ep300, Rarα and
Kat2a using Fugene 6 (Roche). For single transfection, we used 200 ng of each
construct whereas in co-transfection experiments 150 ng of each plasmid was used.
One micro molar RA (Sigma) was added after 24 h of transfection, and 20 h later,
cells were collected and lysed. Renilla luciferase and ﬁreﬂy luciferase activity were
measured using a dual luciferase assay kit (Promega) and a microplate lumin-
ometer (Berthold Centro XS3 LB 960). Five different histone deacetylase inhibitors
were used: Trichostatin A (30–100 nM), Sodium butyrate (1.5–3 mM), Apicidin
(300 nM) (all from Sigma) and LAQ824 (60 nM), Panobinostat (30 nM) (both from
Selleckchem). UNC0638 and UNC0646 (both from Tocris) were used to inhibit
Ehmt2 methyltransferase activity.
For siRNA experiments, NIH3T3 cells were transfected with ON-TARGETplus
Smartpool mouse siRNA (Dharmacon) or ON-TARGETplus non-targeting control
siRNA pool (Dharmacon) using DharmaFECT 1 or DharmaFECT Duo (for
luciferase experiments) reagents (Dharmacon) and following the manufacturer’s
instructions. The ON-TARGETplus Smartpool mouse siRNA were used against the
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following target genes: Rere, Wdr5, Hdac1, Hdac2, Ehmt2, Ep300, and Kat2a. For
single siRNA experiments 100 nM of each siRNA was used for the transfection. In
the case of double siRNA transfections 50 nM of each siRNA was used for
experiments.
Co-immunoprecipitation experiments and western blots. NIH3T3 cells were
cultured in 10 cm cell culture plates overnight to 70–80% conﬂuence and then
transfected with pFlag-Hdac1 alone or together with pMyc-Rere-HA vectors using
Fugene 6 (Roche). NIH3T3 cells were cultured in T-25 ﬂasks overnight to 70–80%
conﬂuence and then transfected with the expression vectors using Fugene 6
(Roche). Cells were collected 24 h post-transfection and lysed with a hypotonic
gentle lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 10 mM EDTA, 0.5%
Triton X-100 and Complete protease inhibitors (Roche)). After the lysis, the NaCl
concentration was raised to 150 mM. Soluble extracts, together with either mouse
IgG (Upstate), M2 anti-FLAG (Sigma) or anti-HA (Sigma), were incubated with
Dynabeads M-280 sheep anti-Mouse IgG (Invitrogen) overnight at 4 °C. Beads
were washed 10 times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.05%
Triton-X100, and then bound protein was eluted using Laemmli sample buffer
(Sigma) and heated at 100 °C for 5 min. Elutions were resolved on 7.5%
polyacrylamide Tris-HCl gels (BioRad) and transferred to polyvinylidene diﬂuoride
membrane (Millipore). Blots were treated according to a standard western blot
protocol.
The following reagents and antibodies were used: mouse IgG (Upstate), M2
anti-Flag (Sigma), anti-HA (Sigma), Dynabeads M-280 sheep anti-mouse IgG
(Invitrogen), Flag-coupled HRP (Sigma), HA-coupled HRP (Roche) and Rarα C-20
(Santa Cruz).
To immunoprecipitate the endogenous WHHERE complex from NIH3T3 cells,
whole cell protein extract prepared with Tris-HCl pH 7.5, 20% glycerol, 0.2 M KCl,
2X PIC and 1 mM DTT was mixed with Rere antibody (Santa Cruz, sc-98145)
coupled with protein G sepharose beads (protein G sepharose 4 fast ﬂow, GE
healthcare) or protein G sepharose beads only (negative control IP) for 1 h rotating
at 4 °C. Beads were washed in a buffer containing 150 mM KCl, 25 mM Tris-HCl
pH 8.0, 10% glycerol, 5 mM MgCl2, 0.1% NP-40, 2X PIC, 1 mM DTT and eluted
after boiling beads in Laemmli buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl pH
6.8, Bromophenol blue 0.02%) followed by western blot analysis against Rere
(Santa Cruz, sc-98145, dilution 1/1000), Hdac1 (Abcam, ab7028, dilution 1/1000),
Hdac2 (Abcam, ab7029, dilution 1/1000) and Wdr5 (Millipore 07-706, dilution
1/1000). All uncropped western blots can be found in Supplementary Figs. 7–9.
Real-time PCR assays. Total mRNA was isolated from NIH3T3 cells using
FastLane Cell One-Step Buffer Set (Qiagen). qPCR experiments were performed
using Quantifast SYBR Green RT-PCR Kit (Qiagen) in a LightCycler 480 II System
(Roche). The following primers from Qiagen (Qiagen Quantitect Primer Assay)
were used—with catalog numbers in brackets: Rere (QT01075774); Wdr5
(QT00111685), Hdac1 (QT02273418), Hdac2 (QT01161657), Ehmt2
(QT00115262), Rarβ (QT00151956), and Rplp0 (QT00249375).
Chromatin immunoprecipitation assay. NIH3T3 cells were grown in 15 cm
dishes and treated with 1 µM of RA (Sigma) for 1 h before collecting. At 70–80%
conﬂuency, cells were crosslinked with 1% formaldehyde at room temperature for
10 min. For ChIP experiments with NIH3T3 cells, 50 µg of chromatin were used
per immunoprecipitation. F9 or NIH3T3 cells were grown in 15 cm dishes and
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Fig. 7 Kat2a but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for
20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n= 4). b Cells transfected with expression plasmids containing human
Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n= 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n= 3).
d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n= 3). e Cells treated either with siRNA for Rere, Ep300, or
Kat2a (n= 4). In all graphs data represent mean± s.e.m. NS—not signiﬁcant, *P< 0.05 and **P< 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ
expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in
wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar= 100 microns
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treated with 0.1 µM and 1 µM of RA (Sigma) 20 h before collecting. At ~80%
conﬂuency, cells were crosslinked with 1% formaldehyde at 37°C for 15 min.
Crosslinking was quenched by the addition of glycine to a ﬁnal concentration of
125 mM for 5 min at room temperature. Cells were lysed in lysis buffer containing
1% SDS, 10 mM EDTA and 50mM Tris-HCl pH 8.0 and protease inhibitors at a
concentration of 3 × 107 cells/ml. Sonication was performed to produce an average
fragment size of ~ 200–1000 bp. Chromatin was diluted ﬁvefold in buffer con-
taining 0.005% SDS, 0.55% Triton X-100, 0.6 mM EDTA, 8.35 mM Tris pH 8.0,
8.35 mM NaCl. Antibodies (5–10 µg per immunoprecipitation) were pre-bound to
a protein A sepharose slurry (0.15 g lyophilized protein A sepharose beads (Sigma)
were resuspended in 1.3 mL 1X TE with 300 µg sonicated salmon sperm DNA
and 1.5 µg BSA). Forty microliters of the resulting slurry was used per
immunoprecipitation. Chromatin was pre-cleared using this slurry without anti-
body and pre-cleared chromatin was then added to the antibody-bead complexes
overnight. Chromatin from ~3 × 106 NIH3T3 or F9 cells was used per immuno-
precipitation. Complexes were washed the next morning for 10 min each with
Buffer A: 0.1% SDS, 1% TritonX-100, 1 mM EDTA, 20 mM Tris-HCl pH 8.0, 50
mM NaCl; Buffer B (same as buffer A except contained 500 mM NaCl; Buffer C:
0.25M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl
pH 8.0, followed by two washes in 1X TE). Beads were then eluted at room
temperature with 1% SDS and 0.1 M NaHCO3, crosslinks were reversed, proteinase
K digestion was performed and DNA was isolated. PCR was performed with the
Fast SYBR Green Master Mix (Applied Biosystems) using a 7500 Fast Real-Time
PCR System (Applied Biosystems). PCR conditions were as follows: 95 °C (20 s)
(1×); 95 °C (3 s) and 60 °C (30 s) (40×). Primer pairs used for the Rar-beta
promoter were: 5′-CAGACTGGTTGGGTCATTTGAA-3′ and 5′-GCGAGT-
GAACTTTCGGTGAAC-3′. Immunoprecipitated DNA amounts were calculated
from a standard curve of input DNA and normalized to rabbit or mouse IgG
immunoprecipitations.
For ChIP assay with mouse embryonic tissue, we modiﬁed the protocol as
follows. E8.75-9.0 embryos were collected from transgenic RARE-LacZ mice in PBS
with Complete protease inhibitors (Roche) and crosslinked with 1% formaldehyde
at room temperature for 15 min. Crosslinking was quenched by the addition of
glycine to a ﬁnal concentration of 125 mM for 5 min at room temperature. The
embryos after dounce homogenization were snap frozen in liquid nitrogen.
Homogenized tissue from 24 embryos was suspended in 960 µl of lysis buffer and
40 µl of tissue lysate was subjected to ﬁve cycles of sonication in 0.5 ml Protein
LoBind Tube (Eppendorf) by Bioruptor (Diagenode) to an average DNA fragment
size of 500 bp, and sonicated chromatin was pooled and homogenized, and then
divided into 24 specimens to a concentration of one embryo per specimen. Twenty
microgram of chromatin were used per immunoprecipitation. A volume of 50 µl of
Dynabeads M-280 Sheep anti-Rabbit or Mouse IgG (Invitrogen) was coupled with
5 µg of antibodies in Blocking Solution (0.1% SDS, 1% TritonX-100, 2 mM EDTA,
20 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1 mg/ml sonicated salmon sperm DNA
and 0.2 mg/ml BSA) at room temperature for 1 h and was used per
immunoprecipitation. Antibody-Protein complex was generated in blocking
solution at 4 °C overnight and then washed for 5 min each with Buffer D: 0.1%SDS,
1% TritonX-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mg/ml;
Buffer E (same as buffer D except contained 500 mM NaCl); 1X TE containing
0.1% SDS, and all solutions contain 10 mg/ml Linear Acrylamide. Beads were
eluted at 55 °C for 1 h with Elution Buffer (1% SDS, 10 mM EDTA, 50 mM
Tris-HCl pH 8.0, 1 mg/ml Proteinase K and 10 mg/ml Linear Acrylamide) and then
heated at 95 °C for 15 min. Eluted DNA was puriﬁed with QIAGEN PCR
puriﬁcation kit. PCR was performed with the Fast SYBR Green Master Mix
(Applied Biosystems) using a 7500 Fast Real-Time PCR System (Applied
Biosystems). PCR conditions were as follows: 95 °C (20 s) (1×); 95 °C (3 s) and
60 °C (30 s) (40×). Primer pairs used for the RARE-LacZ reporter were:
5′-TGCTGCACGCGGAAGA-3′ and 5′-CCACCAATCCCCATATGGAA-3′.
Antibodies used for ChIP are listed in Table 1.
qPCR was performed with LightCycler 480 SYBR Green I Master mix (Roche)
in a LightCycler 480 II System (Roche) using the primers described in
Supplementary Table 1.
Proteomic approach to identify Rere-associated proteins. To identify proteins
binding to Rere, we ﬁrst generated a mouse colony homozygous for both the T-Cre
transgene and the RS-Rere-HA allele. Thus, all the embryos generated by crossing
these mice express Rere-HA only in mesodermal tissues. We collected around 600
E10.5 embryos and prepared whole cell extracts using either a low salt (350 mM
NaCl) or a high salt (420 mM NaCl) extraction buffer (Supplementary Note 1). For
the low salt condition, afﬁnity puriﬁcation was done at 150 mM NaCl; whereas for
the high salt protocol, it was performed at 300 mM NaCl. Each afﬁnity puriﬁcation
was performed on biological replicates of protein extracts from about 50–70
embryos prepared on different days. Two different anti-HA antibodies from Sigma
and Roche were used for the afﬁnity puriﬁcation. For each of the conditions, six
elutions were performed with a HA peptide, and the last elution with SDS 2% to
completely remove all the proteins attached to the beads. Samples were analyzed by
MudPIT as follows: elution 1 run alone, elution 2 and 3 combined and elutions 4 to
7 combined (Supplementary Note 1). A total of 11 and 12 MudPIT analyses were
performed for the low and high salt conditions, respectively (Fig. 1a, b and Sup-
plementary Fig. 2d–f). The same puriﬁcation strategy was applied to embryos from
wild-type females to use as a negative control. Proteins were extracted in either low
or high salt conditions from 108 × 2 and 100 × 2 embryos prepared on different
days, then split in half and afﬁnity puriﬁed using either the Sigma or Roche anti-
HA antibodies; elutions were combined into 3 digested samples as described above
and analyzed independently for a total of 12 MudPIT analyses.
Multidimensional protein identiﬁcation technology. TCA-precipitated protein
samples from mouse HA immunoprecipitations were solubilized in either 30 µl
or 60 µl (for pooled elutions only) of freshly made 0.1 M Tris-HCl pH 8.5, 8 M
urea, 5 mM TCEP (Tris(2-Carboxylethyl)-Phosphine Hydrochloride, Pierce). After
30 min at room temperature, freshly made 0.5 M IAM (Iodoacetamide, Sigma) was
added to a ﬁnal concentration of 10 mM, and the samples were left at room
temperature for another 30 min in the dark. Endoproteinase Lys-C (Roche) was
ﬁrst added at an estimated 1:100 (wt/wt) enzyme to protein ratio, for at least 6 h at
37 °C. Urea was then diluted to 2M with 0.1 M Tris-HCl pH 8.5, CaCl2 was added
to 0.5 mM and modiﬁed trypsin (Promega), 1:100 (wt/wt), was added for over 12 h
at 37 °C. All enzymatic digestions were quenched by adding formic acid to 5%.
Each trypsin-digested sample was analyzed independently by Multidimensional
Protein Identiﬁcation Technology (MudPIT)11, 48. Peptide mixtures were pressure-
loaded onto a 100 µm fused-silica column pulled to a 5 μm tip using a P 2000 CO2
laser puller (Sutter Instruments). The microcapillary columns were packed ﬁrst
with 8 cm of 5 μm C18 reverse phase (RP) particles (Aqua, Phenomenex), followed
by 3 cm of 5 μm strong cation exchange material (Partisphere SCX, Whatman), and
by 2 cm of RP particles49. Loaded microcapillaries were placed in line with LTQ
linear ion trap mass spectrometers (Thermo Scientiﬁc, San Jose, CA, USA)
interfaced with quaternary Agilent 1100 quaternary pumps (Agilent Technologies,
Palo Alto, CA, USA). Overﬂow tubing was used to decrease the ﬂow rate from
0.1 ml/min to about 200–300 nl/min. During the course of a fully automated
chromatography, ten 120-minutes cycles of increasing salt concentrations followed
by organic gradients slowly released peptides directly into the mass spectrometer12.
Three different elution buffers were used: 5% acetonitrile, 0.1% formic acid (Buffer
A); 80% acetonitrile, 0.1% formic acid (Buffer B); and 0.5 M ammonium acetate,
5% acetonitrile, 0.1% formic acid (Buffer C). The last two chromatography steps
consisted in a high salt wash with 100% Buffer C followed by the acetonitrile
gradient. The application of a 2.5 kV distal voltage electrosprayed the eluting
peptides directly into the mass spectrometers equipped with a nano-LC
electrospray ionization source. Each full MS scan (from 400 to 1600 m/z) was
followed by ﬁve MS/MS events using data-dependent acquisition where the ﬁrst
most intense ion was isolated and fragmented by collision-induced dissociation
(at 35% collision energy), followed by the second to ﬁfth most intense ions.
RAW ﬁles were extracted into ms2 ﬁle format50 using RAW_Xtract (J.R. Yates,
Scripps Research Institute). MS/MS spectra were queried for peptide sequence
information on a 157-node dual processor Beowulf Linux cluster dedicated to
SEQUEST analyses51. MS/MS spectra were searched without specifying differential
modiﬁcations against a protein database consisting of 73626 non-redundant mouse
proteins (NCBI, 2006-09-05 release), 177 sequences for usual contaminants
(such as keratins, proteolytic enzymes…), as well as the sequence for mouse Rere
with two HA tags at the C-terminus. In addition, to estimate false discovery rates,
each non-redundant protein entry was randomized. The resulting “shufﬂed”
sequences were added to the database and searched at the same time as the
“forward” sequences. To account for carboxamidomethylation by IAM, +57 Da
were added statically to cysteine residues for all the searches.
Results from different runs were compared and merged using CONTRAST52.
Spectrum/peptide matches were only retained if peptides had to be at least seven
amino acids long and be fully tryptic. The DeltCn had to be at least 0.08, with
Table 1 Antibodies used for ChIP
Antibody Catalog number (Company) Concentration/ChIP
Rere H-113 sc-98415 (Santa Cruz) 10 μg
Wdr5 07-706 (Millipore) ~ 5 μg (1:200)
Hdac1 C-19 sc-6298 (Santa Cruz) 10 μg
Hdac2 H-54 sc-7899 (Santa Cruz) 10 μg
Rarα C-20 sc-551 (Santa Cruz) 10 μg
Rpb1 (total Pol II) PB-7C2 (Euromedex) ~ 3 μg (1:300)
Ehmt2 07-551 (Millipore) 10 μg
H3K9me1 ab9045 (Abcam) 2 μg
H3K9me2 ab1220 (Abcam) 2 μg
H3K4me1 ab8895 (Abcam) 2 μg
H3K4me2 ab32356 (Abcam) 2 μg
H3K4me3 ab8580 (Abcam) 2 μg
H3K27ac ab4729 (Abcam) 2 μg
H3ac 06-599 (Millipore) 2 μg
H4ac 06-598 (Millipore) 2 μg
H3K36me3 ab9050 (Abcam) 2 μg
H3K27me3 ab6002 (Abcam) 2 μg
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minimum XCorrs of 1.8 for singly- charged, 2.0 for doubly- charged, and 3.0 for
triply-charged spectra, and a maximum Sp rank of 10. Finally, combining all runs,
proteins had to be detected by at least 2 such peptides, or 1 peptide with two
independent spectra. Proteins that were subset of others were removed.
NSAF7 (Tim Wen, Stowers Institute) was used to create the ﬁnal report on all
detected proteins across the different runs, calculate their respective Normalized
Spectral Abundance Factor (NSAF) values and estimate false discovery rates
(FDR).
Spectral FDR is calculated as:
FDR ¼ 2 ´ SHUFFLED Spectral Counts
Total Spectral Counts
´ 100:
Protein level FDR is calculated as:
Protein FDR ¼ SHUFFLEDProteins
Total Proteins
´ 100:
Under these criteria the ﬁnal FDRs at the protein and spectral levels were 1.9%
and 0.14%± 0.085, respectively.
To estimate relative protein levels, NSAFs were calculated for each non-
redundant protein, as described in ref. 12, 53, 54:
NSAFð Þi ¼
Spectral Count=Lengthð Þi
PN
k¼1
Spectral Count=Lengthð Þk
:
WHHERE complex puriﬁcation and gel ﬁltration analysis. Protein samples
containing Rere-Flag, Flag-Hdac1, Flag-Hdac2, and HA-Wdr5 analyzed by gel
ﬁltration, were puriﬁed by anti-Flag immunoprecipitation (Flag-IP) from insect
cells SF21 (strain Spodoptera fugiperda) co-expressing the four genes using a
baculovirus expression system, each one cloned into the baculovirus transfer vector
pVL1392 or pVL1393. For immunoprecipitation of the WHHERE complex from
SF21 cells, cells co-expressing Rere-Flag, Flag-Hdac1, Flag-Hdac2, and HA-Wdr5
were lyzed with a buffer containing 0.4 M KCl, 25% glycerol, 20 mM Tris-HCl pH
8.0, 5 mM MgCl2, 0.5% NP-40, 2X complete protease inhibitor cocktail EDTA-free
(Roche) and 1 mM DTT. After centrifugation of the lysate for 10 min at 8000 r.p.m.
at 4 °C, the supernatant containing the whole cell protein extract was collected and
incubated with anti-Flag antibody coupled with agarose beads (anti-Flag M2 afﬁ-
nity gel, Sigma) for 1 h at 4 °C, to perform the Flag-IP. After washing beads in a
buffer containing 150 mM KCl or 500 mM KCl, 25 mM Tris-HCl pH 8.0, 10%
glycerol, 5 mM MgCl2, 0.1% NP-40, proteins were eluted by peptide binding
competition using the Flag-tag peptide DYKDDDDK (2mg/ml ﬁnal) dissolved into
a buffer containing 100 mM KCl, 25 mM Tris-HCl pH 8.0, 10% glycerol, 5 mM
MgCl2, 0.1% NP-40. Proteins eluate was then concentrated on amicon-ultra
centrifugal ﬁlter units (Millipore, membrane cutoff of 30 kDa) before gel ﬁltration
analysis. To study the direct protein–protein interaction between Rere and Wdr5,
Rere-Flag, and HA-Wdr5 were co-expressed and Flag-tagged puriﬁed as described
above. The gel ﬁltration analysis of the puriﬁed complexes was performed on a
Superose 6 PC 3.2/30 (GE Healthcare) mounted on an AKTA micro chromato-
graphy system (GE Healthcare) using a buffer containing 25 mM Tris-HCl pH 8.0,
100 mM KCl, 5 mM MgCl2, and 2% glycerol. Calibration of the column was
performed using a standard calibration kit (BioRad), containing Thyroglobulin
(670 kDa), ɣ-globulin (158 kDa), ovalbumin (44 kDa), myoglobulin (17 kDa),
and Vitamin B12 (1355 Da). The exclusion volume V0 was determined using
calf thymus DNA (> 2000 bp), while the total volume of the column was
measured using L-Tyrosine. For the experiment, 80–100 µl of puriﬁed sample was
injected through an injection loop to the column. Flow rate was set to 40 µl/min
and SEC fractions of 75 µl each were collected throughout the gel ﬁltration run and
analyzed by western blotting to check for the presence of Rere, Hdac1, Hdac2, and
Wdr5. The following antibodies were used for western blot: Rere (Santa Cruz, sc-
98415), Hdac1 (Abcam, ab7028), Hdac2 (Abcam, ab7029), and Wdr5 (Abcam,
ab22512).
Statistics. Statistics were performed using Excel software (Microsoft). Signiﬁcance
of difference was analyzed with a Student’s unpaired two-tailed t-test. All data are
presented as mean± s.e.m. and a P-value of 0.05 was considered signiﬁcant. The
results were presented as the average of at least three independent experiments
unless otherwise stated in the legends.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles or
from the corresponding author upon reasonable request. The mass spectrometry
data set has been deposited in the MassIVE/ProteomeXchange under accession
codes MSV000080920 and PXD006303.
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